Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Sionna Therapeutics, Inc.NASDAQ: SION
Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026
Other non-cash items turns positive
Q1 FY2026 other non-cash items was $289K, compared with -$206K a year earlier. Trailing-twelve-month other non-cash items was -$857K.
Context
- Other non-cash items increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly other non-cash items holds near $289K or moves back toward the trailing-twelve-month quarterly average of -$214.25K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 2.61M USD
- Year-over-year change
- -65.7%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.61M | -65.7% |
| FY2024 | 2024-12-31 | 7.6M | +405.0% |
| FY2023 | 2023-12-31 | 1.51M | +476.3% |
| FY2022 | 2022-12-31 | (400K) | — |
Other Non-Cash Items vs competitors
How SION compares with its peers on the latest reported figures
- SION's LTM Mar 2026 other non-cash items of $857K is the smallest of the 11 companies compared; the peer median is $6.47M.
- Its year-over-year change of -112.2% is the 10th highest of 11, against a peer median of +91.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $49.02M | +235.7% | -48.1% | 72.2% | |
| LTM Jun 2026 | $28.42M | +300.0% | -62.2% | — | |
| LTM Sep 2026 | $24.79M | +3822.1% | — | 9.3% | |
| LTM Mar 2026 | $15.98M | +22.7% | +100.4% | 73.9% | |
| LTM Jun 2026 | $13.93M | +359.3% | — | — | |
| LTM Sep 2026 | $9.23M | -62.8% | +3.5% | — | |
| LTM Mar 2026 | $4.38M | -226.7% | — | 1.0% | |
| LTM Sep 2026 | $3.95M | -52.5% | — | 3525.0% | |
| LTM Mar 2026 | $3.71M | +160.6% | +3.6% | 1.2% | |
| LTM Mar 2026 | $1.12M | -85.1% | -32.0% | 5.6% | |
| LTM Mar 2026 | $857K | -112.2% | — | — | |
| Peer median (excluding SION) | $6.47M | +91.6% | -14.2% | 9.3% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.